# Rivastigmine

NDC: 70771-1950
Generic name: Rivastigmine
Labeler / Manufacturer: Zydus Lifesciences Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: PATCH, EXTENDED RELEASE
Routes: TRANSDERMAL
Marketing started: 20190306

FDA application: ANDA206318

## Active ingredients

- RIVASTIGMINE: 9.5 mg/24h

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70771-1950"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70771-1950
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=966d59ea-5cea-4fef-8b96-e0efe885caf4